Opiniones de EFSA relativas a la reducción de factor de riesgo de una enfermedad (Art.14.1.a)
Julio 2012
- Combination of plant sterols and Cholesternorm mix and reduction of cholesterol concentrations. (Q-2009-00237, Q-2011-01114)
Mayo 2012
- Plant Sterols and Stanols and Blood Cholesterol (Q-2011-01241)
- Plant Stanol Esters and Blood Cholesterol (Q-2011-00851)
Febrero 2012
- Isolated soy protein and reduction of blood LDL-cholesterol concentrations (EFSA-Q-2011-00784)
Diciembre 2011
- Barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease (EFS-Q-2011-00798)
- Barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease (EFSA-Q-2011-00799)
Septiembre 2011
- Vitamin D and risk of falling (EFSA Q-2010-01233)
Mayo 2011
Abril 2011
Febrero 2011
- Calcium-containing fruit juices and the reduction of tooth demineralisation (EFSA-Q-2009-00501)
- Water and reduced risk of development of dehydration and of concomitant decrease of performance (EFSA-Q-2008-05014)
- Oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease (EFSA-Q-2008-681)
Octubre 2010
- Health claim related to sugar free chewing gum and reduction of tooth demineralisation which reduces the risk of dental caries (EFSA-Q-2010-00119)
- Health claim related to sugar free chewing gum and neutralisation of plaque acids which reduces the risk of dental caries (EFSA-Q-2010-00120)
Septiembre 2010
- Health claim related to OPC Plus and reducing the risk of chronic venous insufficiency by increasing microcirculation (EFSA-Q-2009-00751)
Julio 2010
- Health claim related to soy protein and reduction of blood cholesterol concentrations (EFSA-Q-2009-00672)
Mayo 2010
- Health claims on calcium and vitamin D and the reduction of the risk of osteoporotic fractures by reducing bone loss (EFSA-Q-2009-00940)
Diciembre 2009
- Scientific Opinion on the substantiation of a health claim related to a combination of bifidobacteria and decreasing potentially pathogenic intestinal microorganisms (EFSA-Q-2009-00224)
- Scientific Opinion on the substantiation of a health claim related to a Uroval® and urinary tract infection (EFSA-Q-2009-00600)
Octubre 2009
- Glucosamine hydrochloride and reduced rate of cartilage degeneration (EFSA Q-2009-00412)
- OPC Premium™ and the reduction of blood cholesterol (EFSA-Q-2009-00454)
Agosto 2009
- Calcium + Vitamin D3 chewing tablets and bone loss (EFSA-Q-2008-721)
- Lycopene-whey complex (bioavailable lycopene) and risk of atherosclerotic plaques (EFSA-Q-2008-703)
Julio 2009
- Danacol® and blood cholesterol (EFSA-Q-2008-779)
- Plant Stanols and Plant Sterols and Blood LDL-Cholesterol (EFSA-Q-2009-00530, EFSA-Q-2009-00718)
- BimunoTM and reduction of the bad bacteria that can cause travellers’ diarrhoea (EFSA-Q-2009-00232)
Febrero 2009
- Melgaço mineral water and reduction of glycaemia - Scientific substantiation of a health claim related to Melgaço® mineral water and reduction of glycaemia (EFSA Q-2008-219)
Noviembre 2008
- Xylitol chewing gum/pastilles and reduction of the risk of tooth decay (EFSA Q-2008-321)
- Plant stanol esters and blood cholesterol (EFSA Q-2008-118)
Octubre 2008
- Evolus® and reduce arterial stiffness (EFSA Q-2008-218)
Agosto 2008
- Plant Sterols and Blood Cholesterol (EFSA Q-2008-085)
- Femarelle® and bone mineral density (EFSA Q-2008-078)
- NeOpuntia® and blood lipid parameters (EFSA Q-2008-214)